AzurRx BioPharma Engages PPD to Manage Clinical Trial for Niclosamide as Treatment for COVID-19 Gastrointestinal Infections

NEXT STORY
Skylight Health Names Paul Kulas Senior Vice President of Operations
PREV STORY
US C-arms Market to Reach USD 1146.1 Million at 4.4% CAGR by 2027; Increasing Number of Orthopedic Disorders will Emerge in Favor of Market Growth, says Fortune Business Insights™
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Syndax Pharmaceuticals Reports Fourth Quarter and Year-end 2016 Financial Results and Provides Clinical and Business Update

Encore 601 refractory melanoma cohort to proceed to second stage of Phase 2; pre-specified ...

author_avatar
NASDAQ Market News

InflaRx Completes Enrollment in Vilobelimab (IFX-1) European Phase II Study in ANCA-associated Vasculitis

author_avatar
NASDAQ Market News

electroCore Provides Update on Availability of gammaCore Sapphire™ CV for the Acute Treatment of Asthma Exacerbations in Known or Suspected COVID-19 Patients

author_avatar
NASDAQ Market News